Back to search

Article

Performance of Lateral Flow Assays for SARS-CoV-2 Compared to RT-qPCR

2021-12-22

Abstract excerpt

The COVID-19 pandemic represents a worldwide public health challenge requiring the early identification and isolation of infected individuals to prevent further spreading of the disease. Lateral Flow Assays (LFAs), also known as antigen rapid diagnostic tests, are broadly available, inexpensive point-of-care diagnostic tools. The use of these tests has been questioned, however, particularly concerning their allege...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
68a93bde-d6a1-53cc-be9c-4091e3d664d0
DOI
10.2139/ssrn.3991640
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Performance of Lateral Flow Assays for SARS-CoV-2 Compared to RT-qPCRDOI 10.2139/ssrn.3991640
Select a neighboring publication to make it the new centre.